Showing results (1-10 of 140) with videos related to
Sort By:
Pageof 14
Deutsche Medizinische Wochenschrift (1946)|April 30, 2015
[Prevention of cardiovascular disease in patients with type 2 diabetes]Corinna Lebherz, Michael LehrkeCurrent Atherosclerosis Reports|August 3, 2014
AAV-mediated gene therapy for atherosclerosisMichael Lehrke, Corinna LebherzAtherosclerosis|November 26, 2013
Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe⁻/⁻ miceMathias Burgmaier, Ana Liberman, Julia Möllmann, et al.Diabetes|August 21, 2010
Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat dietMelanie Becker, Katja Rabe, Corinna Lebherz, et al.Diabetes, Obesity & Metabolism|December 6, 2016
The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolismJulia Möllmann, Florian Kahles, Corinna Lebherz, et al.Current Atherosclerosis Reports|June 7, 2013
C-Peptide and its career from innocent bystander to active player in diabetic atherogenesisCorinna Lebherz, Nikolaus MarxCell Metabolism|August 2, 2005
Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalphaMichael Lehrke, Corinna Lebherz, Segan C Millington, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 19, 2025
Development of a Mouse Model of Uremic Cardiomyopathy: Investigating the Impact of Chronic Kidney Disease on Cardiac Function and Signaling PathwayJulia Moellmann, Katja Glandien, Barbara M Klinkhammer, et al.Diabetes, Obesity & Metabolism|July 24, 2018
Myocardial infarction is sufficient to increase GLP-1 secretion, leading to improved left ventricular contractility and mitochondrial respiratory capacitySebastian Diebold, Julia Moellmann, Florian Kahles, et al.Cardiovascular Diabetology|February 5, 2016
Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolismCorinna Lebherz, Florian Kahles, Katja Piotrowski, et al.Pageof 14